Stocks · News reference
Wall Street analysts upgraded HYLN, WYFI, SM. Analyst ratings and price targets available.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Wall Street analysts changed ratings for top names. Visit our analyst ratings page for details. SGP initiated with Outperform, $39 PT.
Wall Street analysts revised their ratings for top stocks. Visit benzinga.com/analyst-stock-ratings for all changes, including upgrades and downgrades.
Wall Street analysts changed outlook on top names. Check analyst ratings page for all changes. See what analysts think of MTN stock.
Top Wall Street analysts changed outlook on top names. See analyst ratings page for all changes. STUB downgraded, MNPR neutral, BETR.
Kaplan Fox has filed class action lawsuits against three companies: Hims & Hers for allegedly failing to disclose immediate prescription charges, sharing health data with third parties, and making subscription cancellations difficult; Hyliion Holdings for undisclosed issues during May-June 2026; and Innventure for regulatory concerns from November 2025 to August 2026. Investors with losses are encouraged to contact the firm before respective deadlines.
A class action lawsuit has been filed against Hyliion Holdings Corp. in the U.S. District Court for the Western District of Texas. The lawsuit alleges that company executives made false and misleading statements about a recently announced business deal with a newly formed entity lacking actual operations, and that CEO Thomas Healy and CFO Jon Panzer timed the announcement to facilitate insider trading. Investors who purchased Hyliion stock between May 12, 2026 and June 23, 2026 are eligible to participate, with a deadline of October 27, 2026 to apply as lead plaintiff.